These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20210915)

  • 61. Diabetes treatment in patients with renal disease: Is the landscape clear enough?
    Ioannidis I
    World J Diabetes; 2014 Oct; 5(5):651-8. PubMed ID: 25317242
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Updates on the management of diabetes in dialysis patients.
    Rhee CM; Leung AM; Kovesdy CP; Lynch KE; Brent GA; Kalantar-Zadeh K
    Semin Dial; 2014 Mar; 27(2):135-45. PubMed ID: 24588802
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country.
    Kute VB; Godara SM; Shah PR; Jain SH; Engineer DP; Patel HV; Gumber MR; Munjappa BC; Sainaresh VV; Vanikar AV; Modi PR; Shah VR; Trivedi HL
    Int Urol Nephrol; 2012 Feb; 44(1):269-74. PubMed ID: 21805084
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome of renal transplantation in patients with diabetic nephropathy -- a single-center experience.
    Kute VB; Vanikar AV; Trivedi HL; Shah PR; Goplani KR; Gumber MR; Patel HV; Godara SM; Modi PR; Shah VR
    Int Urol Nephrol; 2011 Jun; 43(2):535-41. PubMed ID: 21107691
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
    Chaudhuri A; Dandona P
    Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
    Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selection and dosing of medications for management of diabetes in patients with advanced kidney disease.
    Reilly JB; Berns JS
    Semin Dial; 2010; 23(2):163-8. PubMed ID: 20210915
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting].
    Granata A; Insalaco M; Di Nicolò P; Scarfia VR; Russo L; D'anna G; Lentini P; Fiorini F; Fatuzzo P
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.
    Tornio A; Niemi M; Neuvonen PJ; Backman JT
    Trends Pharmacol Sci; 2012 Jun; 33(6):312-22. PubMed ID: 22475684
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.